Liskow is honored to share that the JDRF Southern Texas Chapter awarded the firm the 2022 Corporate Partner of the Year Award. From funding innovative research to advocating for government action to providing a support structure for local communities, no other organization does more to fight type 1 diabetes (T1D) than JDRF.
Liskow takes pride in supporting JDRF’s mission and has supported the JDRF Promise Ball Gala in Houston for the last decade. Liskow was the inaugural sponsor of the Casino Afterparty associated with the Annual Promise Ball Gala nearly a decade ago and has been the sole sponsor ever since. This year the Gala raised more than $3.6 million to fund research to make Type 1 Type None.
Michael Golemi, a shareholder at Liskow and the head of the firm’s Houston office, is very involved in the JDRF Southern Texas Chapter and has served in various leadership roles. He currently serves on the Houston Community Board of Directors. He has served as a Board member for the Gulf Coast Chapter and was recently the Promise Ball Gala Underwriting Chair. Michael has served on several JDRF committees, including the Corporate Development Committee (2018-2021), the 2018 Promise Ball Gala Fund A Cure Committee, the 2016 Promise Ball Gala Fund A Cure Committee, the 2015 Board of Directors Fast Start Award, the 2015 Promise Ball Gala Fund A Cure Committee, and the 2014 Promise Ball Gala Underwriting Committee. “Helping JDRF work toward improving treatments and eventually finding a cure for my daughter’s Type I Diabetes is a passion of mine,” shared Michael.
Nearly every advancement in diabetes treatment over the last forty years has been funded, at least in part, by JDRF, including 70 clinical trials in the last few years alone. For more information about JDRF, its impact, and ways to support JDRF, visit https://www.jdrf.org/impact/research/.